Factors affecting proteoglycan synthesis and structure that modify the interaction with lipoproteins

Phosphorylated Troglitazone Activates PPARγ and Inhibits Vascular Smooth Muscle Cell Proliferation and Proteoglycan Synthesis

(2009) Peter J Little et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Pyrido-Pyrimidine Derivative CYC10424 Inhibits Glycosaminoglycan Changes on Vascular Smooth Muscle-derived Proteoglycans and Reduces Lipoprotein Binding

(2009) Mandy L Ballinger et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Early atherosclerosis in humans: role of diffuse intimal thickening and extracellular matrix proteoglycans

(2008) Y. Nakashima et al.   CARDIOVASCULAR RESEARCH

Hyperelongated biglycan: the surreptitious initiator of atherosclerosis

(2008) Peter J Little et al.   CURRENT OPINION IN LIPIDOLOGY

Clinical trials with thiazolidinediones in subjects with Type 2 diabetes – is pioglitazone any different from rosiglitazone?

(2008) Sheila A Doggrell   EXPERT OPINION ON PHARMACOTHERAPY

Smad and p38 MAP Kinase-mediated Signaling of Proteoglycan Synthesis in Vascular Smooth Muscle

(2008) Harsha Dadlani et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Adiponectin as an inducer of decorin synthesis in cultured vascular smooth muscle cells

(2008) Chika Yamamoto et al.   LIFE SCIENCES

Thrombin regulates vascular smooth muscle cell proteoglycan synthesis via PAR-1 and multiple downstream signalling pathways

(2008) Melanie E. Ivey et al.   THROMBOSIS RESEARCH

Glucosamine inhibits the synthesis of glycosaminoglycan chains on vascular smooth muscle cell proteoglycans by depletion of ATP

(2008) Peter J. Little et al.   ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY

The effect of PPAR ligands to modulate glucose metabolism alters the incorporation of metabolic precursors into proteoglycans synthesized by human vascular smooth muscle cells

(2008) Julie Nigro et al.   ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY